Clinical Outcome of Vinpocetine in Diabetic Nephropathy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The goal of this controlled, randomized, clinical trial is to evaluate the effect of vinpocetine on clinical outcomes on the diabetic nephropathy patients. The following will be evaluated; anthropometrics, kidney functions, glucose panel, lipid panel, ICAM-1, quality of life. Participants will receive either vinpocetine or placebo, twice daily for 3 months.
Epistemonikos ID: d7edbdd86ac7c31533c4f7a714aa117fa6f10ec1
First added on: Jul 01, 2024